Endothelium-dependent and cyclooxygenase-dependent cutaneous vasodilatation is blunted in young men with hypertensive parents by Hirst, Amy & Marshall, Janice
 
 
University of Birmingham
Endothelium-dependent and cyclooxygenase-
dependent cutaneous vasodilatation is blunted in
young men with hypertensive parents
Hirst, Amy; Marshall, Janice
DOI:
10.1097/HJH.0000000000001794
License:
None: All rights reserved
Document Version
Peer reviewed version
Citation for published version (Harvard):
Hirst, A & Marshall, J 2018, 'Endothelium-dependent and cyclooxygenase-dependent cutaneous vasodilatation
is blunted in young men with hypertensive parents', Journal of Hypertension, vol. 36, no. 11, pp. 2140-2147.
https://doi.org/10.1097/HJH.0000000000001794
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
  
 
Endothelium- and COX-dependent cutaneous vasodilation is blunted in young men with 
hypertensive parents 
 
Amy Hirst 
&  
Janice M Marshall 
 
Institute of Cardiovascular Science 
College of Medical & Dental Sciences 
University of Birmingham 
Birmingham 
B15 2TT UK 
Short title: Cutaneous vasodilation in hypertensive offspring 
Word count = 5068 
Corresponding author: Professor Janice M Marshall, Institute of Clinical Science, College 
of Medical & Dental Sciences, University of Birmingham, Vincent Drive, Birmingham B15 
2TT UK 
  
 2 
Abstract 
Background. Across ethnicities, offspring of parents with essential hypertension (OH) have 
higher risk of hypertension than offspring of normotensives (ON).  Sympathetic hyperactivity 
and reduced nitric oxide availability have been reported in normotensive OH, but the role of 
vasodilator cyclooxygenase (COX) products is unclear.  
Methods. In 12 OH and 12 ON men (19-24 years old), each group comprising 6 White 
Europeans (WEs) and 6 South Asians (SAs) with resting ABP <129/89mmHg, reactive 
hyperaemia and responses evoked by iontophoretic pulses of acetylcholine (ACh) were 
recorded in forearm skin by laser Doppler fluximetry before and after COX inhibition with 
aspirin. 
Results. Peak reactive hyperaemia) was larger in ON than OH (71.0±7.8 vs 43.4±8.3 
perfusion units (PU); P<0.05). It was attenuated by COX inhibition in ON (24.8±5.2PU, 
P<0.01), not OH (54.2±7.5PU).   Similarly, increases in perfusion evoked by ACh were 
greater in ON than OH (169.1±20.4 vs 142.1±19.9PU; P<0.05) and attenuated by COX 
inhibition in ON (94.5±13.7; P<0.05), not OH (132.6±16.1PU).  Considering ethnicities, 
ACh-evoked dilation, though not reactive hyperaemia was greater in WEs than SAs 
(176.8±21.7 vs 130.4±15.0; P<0.01; 61.0±8.7 vs 51.7±9.2PU).  However, within both WEs 
and SAs, COX inhibition attenuated reactive hyperaemia and ACh-induced dilatation in ON, 
but not OH.   
Conclusions. Reactive hyperaemia and ACh-evoked dilatation in cutaneous circulation are 
blunted in young, normotensive OH relative to ON men irrespective of WE, or SA ethnicity 
and are attributable to impaired contribution of COX vasodilator products in OH.  These 
features may provide early markers of endothelial dysfunction that contribute to hypertensive 
risk in OH men.  
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Abbreviations.  ABP: arterial blood pressure; ACh: acetylcholine, COX: cyclooxygenase; 
CV: coefficient of variation; CVD: cardiovascular disease; CYP 2C: cytochrome P450 
epoxygenase; EDHF: endothelium-dependent hyperpolarising factor; FMD: flow mediated 
dilatation; NO: nitric oxide; OH: offspring of hypertensives; ON: offspring of normotensives; 
PU: perfusion units; PG: prostaglandin; PGI2: prostacyclin; RCF: red cell flux; SA: South 
Asians; WE: White Europeans 
 
Condensed Abstract.  In normotensive young men, aged 19-24 years, who were offspring of 
hypertensive or normotensive parents (OH, ON respectively), we tested the contribution of 
cyclooxygenase (COX) products to cutaneous vasodilatation evoked as reactive hyperaemia, 
or by iontophoresis of acetylcholine (ACh).  Equal numbers of OH and ON were White 
European (WE) and South Asian (SA). COX inhibition attenuated reactive hyperaemia and 
ACh-evoked vasodilatation in OH only, irrespective of WE, or SA ethnicity.  These novel 
findings indicate that a blunted contribution of vasodilator prostaglandins to cutaneous 
vasodilatation precedes development of hypertension and may contribute to its pathogenesis   
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INTRODUCTION 
Essential hypertension is a multi-factorial condition with an established familial component 
that crosses ethnicities, at least amongst those of Black African, White European, Japanese 
and South Asian descent [1-4].  Given evidence that raised sympathetic nerve activity 
contributes to the development of hypertension [5], it is not surprising that black and white 
American teenage girls and boys who were offspring of hypertensive parents (OH), showed 
greater pressor responses to mental stress than those with normotensive parents (ON) [6]. 
Further, in young European men (mean age 27 years), mental stress evoked significant 
increases in muscle sympathetic nerve activity in OH, but not ON [7].
 
However, there is also evidence that endothelium-dependent dilatation is blunted in young 
OH.  Thus, flow-mediated dilatation (FMD) of the brachial artery, was smaller in young OH, 
than ON men and women [8].  Further, vasodilator responses evoked in circulation of whole 
forearm by acetylcholine (ACh) infusion were blunted in normotensive OH men and women, 
but normalised to those of ON by infusion of L-arginine, the substrate for NO synthesis.  By 
contrast, cyclooxygenase (COX) inhibition had no effect on ACh-induced forearm dilatation 
in OH, or ON men and women [9].
 
  It was therefore argued that vasodilator prostaglandins 
(PGs) make no contribution to endothelium-dependent vasodilatation in the forearm of OH or 
ON, but the NO pathway is defective in young OH [10].
 
  In a subsequent, longitudinal study, 
L-arginine enhanced ACh-induced forearm vasodilatation in patients with essential 
hypertension who were <30 years old, and at >30 years, COX inhibition enhanced ACh 
dilator responses.  Similar changes occurred in normotensives, but at 45-60 and >60 years old 
respectively [11].  Thus, both ageing and hypertension were accompanied by impairment of 
the NO pathway followed by up-regulation of a vasoconstrictor influence of the COX 
pathway, but the changes occurred at a younger age during development of hypertension. 
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Clearly, these studies on whole forearm circulation did not allow assessment of the 
contributions of vasodilator PGs [9].  However, forearm circulation includes skeletal muscle 
and cutaneous circulations; vasodilator PGs contribute to endothelium-dependent dilatation in 
the cutaneous circulation of young healthy subjects and their contribution is lost with aging 
and cardiovascular disease [11-14].
 
Thus, in the present study, we hypothesised that endothelium-dependent dilatation is impaired 
in cutaneous circulation of forearm in young adult OH men relative to ON men and that 
imbalance in the COX pathway contributes to this.  We focussed on men because oestrogen 
increases production of prostacyclin (PGI2), and decreases production of vasoconstrictor 
prostanoids in hypertension [15,16].  These effects seemed likely to complicate comparison of 
findings in young ON and OH women and to justify a separate study on women.  Since we 
intended to recruit subjects from a student population that is multi-ethnic, we decided to 
include White Europeans (WEs) and South Asians (SAs). We tested our hypotheses by 
recording changes in forearm cutaneous red cell flux (RCF) evoked during reactive 
hyperaemia and iontophoresis of ACh, before and after COX inhibition.  
  
 6 
METHODS 
Experiments were performed on young, healthy male volunteers, aged 19-24 (mean age ± 
SEM: 20.9±0.28 years), who were students of the University of Birmingham.  Inclusion 
criteria were that they should be free from known cardiovascular or respiratory disorders, 
non-smokers and that one or both parents should have essential hypertension, or neither 
parent was known to have hypertension (OH, ON respectively).  The study was approved by 
the University Research Ethics Committee and performed in accordance with the Helsinki 
Declaration.  Each subject gave informed consent. 
Each subject attended the laboratory twice.  In brief, on the first visit, anthropometric data 
were collected, they were familiarised with the equipment and completed a questionnaire on 
ethnicity, family medical history, diet, smoking, alcohol consumption and level of physical 
activity. Dietary information included assessment of weekly consumption of Vitamin C-
containing fruit and vegetable portions as an index of anti-oxidant vitamin C intake, oily fish 
portions as an index of omega-3-fatty acids and Vitamin D. Physical activity was rated as sedentary 
or elective exercise rated as low, medium, high scored as time spent/week (see Table 1). All were 
White European (WE), or South Asian (SA) and normotensive; resting arterial blood 
pressure: <139/89 mmHg.   
For the second visit, the subject attended the laboratory in the morning.  For five days prior to 
this, they were asked to refrain from any dietary supplements containing vitamin C.  
Additionally, they were asked not to consume any vasoactive drugs, including non-steroidal 
anti-inflammatories, or alcohol for 24 h and to avoid caffeine, heavy meals and vigorous 
exercise for at least 4 h.  Each subject acclimatised for 20-30 min and arterial blood pressure 
(ABP) was recorded by sphygmomanometry. Thereafter, ABP was continuously recorded by 
photoplethysmography via a finger cuff [17,18].  A laser Doppler probe inserted into an 
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iontophoresis chamber filled with a 1% solution of ACh in distilled, de-ionised sterile water, 
was fixed to the left forearm [17,18], to continuously monitor forearm skin perfusion, as 
cutaneous red cell flux (RCF) in perfusion units (PU). 
Experimental protocol. Following baseline recordings for 5 min, reactive hyperaemia was 
recorded following arterial occlusion at 200 mmHg for 3 min, until perfusion returned to 
baseline again.  ACh was then delivered by iontophoresis: 7 pulses of 0.1 mA and an 8th 
pulse of 0.2 mA for 20s each, separated by 60s intervals. Recordings of RCF and ABP were 
made continuously until 5 min following the final iontophoretic pulse [17,18].  
 
The subject drank orange squash containing 600mg aspirin.  The iontophoresis chamber and 
probe were then placed on a different site on the same arm, with a similar baseline as the 
original site: this was done because skin perfusion remained high for 30-60min following 
ACh iontophoresis.   The protocol was repeated 30 min after aspirin, when COX inhibition is 
maximal [17,18].  
Placebo/reproducibility protocol.  The protocol was performed on 8 ON subjects who drank 
orange squash containing no aspirin (placebo) to test for reproducibility of reactive 
hyperaemia and ACh-evoked responses at different sites on forearm skin.   
Data analyses.   
For reactive hyperaemia, RCF was measured as change from baseline at peak, 30s, 1 and 2 
min after release of occlusion.  Responses evoked by ACh were calculated as change from 
baseline to maximal RCF for each iontophoresis pulse; a compacted mean for each subject 
was also calculated as the average of these changes [17,18].  Differences between and within 
ON and OH groups were assessed by two-way ANOVA and two-way repeated measures 
ANOVA respectively.    For reactive hyperaemia, Scheffe´'s post hoc test was used to 
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determine times at which responses differed.  Compacted means for ACh responses were 
compared between and within groups by Student’s un-paired and paired t-tests respectively.  
Anthropometric and baseline data were compared between OH and ON with one-way 
ANOVA.  Comparable analyses were performed between and within the 12 WEs and 12 SAs 
and for the subgroups of OH and ON within WEs and SAs.  Power calculations based on 
previous and pilot data indicated that a subgroup size of 6 was sufficient to detect a 50% 
reduction in peak reactive hyperaemia and a 30% reduction in mean ACh responses after 
aspirin with 80% power in both the WE and SA ONs at P<0.05.  For the placebo protocol, a 
coefficient of variation (CV) was calculated on data collected on repetition of the stimuli.  P 
<0.05 was considered significant throughout. 
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RESULTS 
There were no significant differences between OH and ON groups for anthropometric, 
cardiovascular or lifestyle characteristics (Table 1). Baseline RCF values were not 
significantly different between OH and ON before (13.0±0.7 vs 13.3±0.7PU respectively), or 
after aspirin (14.7±1.1vs 13.8±0.7PU); P>0.05 in each case.  
Reactive hyperaemia  
Peak reactive hyperaemia was substantially higher in ON than OH, the disparity being 
maintained until 30s (Figure 1A cf 1B).  By contrast, after aspirin, reactive hyperaemia was 
greater in OH, than ON (Figure 1B).  Within ON, reactive hyperaemia was significantly 
attenuated by aspirin (Figure 1A & C).  By contrast, aspirin had no significant effect on peak 
reactive hyperaemia in OH (Figure 1B); it was attenuated by >50% in 2 individuals, 
augmented by >30% in 5, and changed by <10% in the remainder (Figure 1D). 
ACh-evoked dilatation 
Before aspirin, cutaneous vasodilator responses evoked by ACh were blunted in OH relative 
to ON (Figure 2A cf 2B).  By contrast, following aspirin, ACh-evoked responses were 
blunted in ON relative to OH (Figure 2B).  Within groups, ACh-evoked responses were 
attenuated after aspirin in ON (see Figure 2A & C), the mean response decreasing from 
169.1±20.4 to 95.4±13.7 PU (P<0.01). By contrast, aspirin had no significant effect on ACh-
evoked responses in OH (Figure 2B & D); they were attenuated by ≥30% from control 
response in 3 individuals, augmented by 15-40% in 4 and changed by <10% in the remainder.  
Comparisons between White Europeans (WEs) and South Asians (SAs).  None of the baseline 
characteristics was significantly different between SAs and WEs except diastolic pressure and 
MABP, which were higher in SAs (Table 2).  Peak reactive hyperaemia was not significantly 
different between SAs and WEs before or after aspirin (Figure 3A & B). Moreover, aspirin 
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did not cause significant attenuation of peak hyperaemia in WEs or SAs.   By contrast, both 
before and after aspirin, vasodilator responses evoked by ACh were blunted in SAs relative to 
WEs (Figure 4A & B), but any effect of aspirin did not reach statistical significance in either 
ethnicity (P=0.12 in WEs; P= 0.14 in SAs).   
 
Considering the effects of aspirin within the ON and OH subgroups of WEs and SAs, reactive 
hyperaemia was attenuated by aspirin in ONs of both WEs and SAs (Figure 3C&D), but not 
in OHs of either ethnicity (Figure 3E & F).  Similarly, within WEs and SAs, ACh responses 
were attenuated by aspirin in ON, but not OH (Figure 4 C-F): mean ACh-evoked responses 
were reduced from 186.0±34.0 to 98.2±22.8PU in ON WEs and from 143.1±18.2 to 
120.6±16.8PU in ON SAs (P=0.02, 0.03 respectively).  
  
Placebo/reproducibility protocol.  There was no significant difference between two different 
sites on the forearm of ON subjects for reactive hyperaemia, or for ACh-evoked responses.  
Peak reactive hyperaemia, was 83.4±7.6 vs 83.1±9.2 PU at sites 1 and 2 respectively with a 
CV between paired values of 7.6%.  Mean ACh-evoked dilatation was 139.9±19.0 vs 
149.6±20.6 PU at sites 1 and 2 respectively with a CV of 4.9%.   
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DISCUSSION 
The present study showed that both reactive hyperaemia and dilatation evoked in cutaneous 
circulation by the endothelium-dependent dilator ACh were blunted in young OH men 
relative to ON men.  Further, COX inhibition with aspirin attenuated reactive hyperaemia and 
the ACh-evoked responses in ON, but not in OH.  
Impaired endothelial-dependent dilatation in cutaneous circulation of OH 
That forearm cutaneous vasodilatation evoked by iontophoresis of ACh was blunted in young 
OH men, is consistent with vasodilatation induced in whole forearm by infusion of ACh being 
blunted in OH men and women aged 23-24 y [9]; our finding that reactive hyperaemia was 
blunted is novel. There is a structural limitation on maximal vasodilatation and rarefaction of 
capillaries in essential hypertension, and it has been suggested these changes begin early in 
the development of hypertension [19].  However, it is unlikely structural abnormalities 
explain the present results for in young men (22-33 y) who were ON or OH, but had normal, 
or high resting ABP, only the hypertensive OH group showed reduced maximal vasodilatation 
and capillary rarefaction in forearm cutaneous circulation [20].   Thus, blunted endothelium-
dependent dilatation in the young OH men is the more probable explanation.   
Contribution of COX products to cutaneous vasodilatation.  That COX inhibition attenuated 
ACh-evoked cutaneous dilatation of ON, but not OH men contrasts with the lack of effect of 
COX inhibition on ACh- evoked dilatation in the whole forearm of mixed male/female groups 
of 8 ON and 10 OH [9].  The simplest explanations for this disparity are that responses 
evoked by ACh in skeletal muscle overshadowed those in cutaneous circulation and/or 
inclusion of women confounded the issue [15,16].  Since COX inhibition also attenuated 
reactive hyperaemia in the cutaneous circulation of young ON, we deduce that vasodilator 
PGs, probably prostacyclin (PGI2) the commonest endothelial PG [21], contribute to both 
vasodilator responses in cutaneous circulation of young ON, but not OH men.   
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Our finding that COX inhibition hardly changed peak reactive hyperaemia or ACh-evoked 
dilatation in 40% of OH, and substantially augmented them in ~40% of OH agrees with 
evidence that IP receptors for PGI2 become dysfunctional during development of hypertension 
in young spontaneously hypertensive rats and with ageing, while the TP receptors that 
respond to thromboxane and mediate vasoconstriction, become responsive to PGI2 [21].
 
 
Accordingly, a TP receptor antagonist augmented ACh-evoked dilatation and FMD in patients 
with coronary artery disease or atherosclerosis [22,23]. We acknowledge that TP receptor 
inhibition did not affect reactive hyperaemia in the skin of normotensive men aged 20-30 y 
[24], but their OH/ON status was not recorded.  In view of the present results, a study on TP 
receptor inhibition on young OH and ON men would seem justified. 
The question arises as to why the cutaneous dilator responses that persisted after COX 
inhibition were substantially larger in OH, than ON men.  COX products can inhibit NO 
synthesis in cutaneous circulation [25].  Thus, COX inhibition might have allowed NO to 
make a larger contribution to ACh-evoked dilatation and reactive hyperaemia in OH, than ON 
men.  This is unlikely given NO makes little contribution to either response in cutaneous 
circulation [13,26-29] and given NO availability is attenuated during development of 
hypertension in young OH men [9,10].  Alternatively, COX inhibition may have revealed the 
dilator influence of endothelium-derived hyperpolarising factor/s (EDHFs), which include a 
cytochrome P450 epoxygenase (CYP 2C) metabolite [26,30,31].
 
 EDHFs provide a dilator 
reserve early in endothelial dysfunction [21] and CYP 2C metabolites compensated for 
impaired NO availability in the forearm of newly diagnosed hypertensives who were OH [31].  
Thus, CYP 2C metabolites may help maintain cutaneous vasodilator responses of young OH 
men at a stage when the dilator influences of PGs are deficient. This remains to be explored. 
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In previous studies, the effects of COX inhibition on cutaneous circulation of normotensive 
subjects have been highly variable.  COX inhibition attenuated ACh-evoked dilatation in 6 
men aged 23-36 y [11], in mixed male/female groups of 12, 23 or 11 subjects of 23-30 y 
[13,14,32] and reactive hyperaemia in 6 men and women aged 27-40 y [12].  By contrast, 
COX inhibition had no effect on these responses in mixed groups of 9, or 6 men and women 
aged 18-30 y [33,34], but augmented reactive hyperaemia in 12 men and women aged 19-25 y 
[25].  Given the small group sizes, the influences of gender and age on the contributions of 
COX products [13,15-18] and the fact that ON/OH status was not considered, it seems likely 
these variable outcomes reflected within group variability. Indeed, the present results indicate 
that in healthy men in young adulthood (19-24 y), of similar life styles and levels of physical 
activity, ON/OH status is the dominant factor determining the effects of COX inhibition on 
reactive hyperaemia and ACh-evoked dilatation. The high reproducibility of both responses in 
ON men who received placebo rather than COX inhibitor is consistent with that proposal.    
Effects of ethnicity 
We recruited equal numbers of WE and SA in the ON and OH groups, knowing the 
prevalence of cardiovascular disease (CVD) is higher in SAs and associated with endothelial 
dysfunction [35].
 
 Accordingly, diastolic pressure was higher in the young SA than WE men 
consistent with increased peripheral resistance in young SA men.  Further, ACh-evoked 
dilatator responses though not reactive hyperaemia, were blunted in young SA, relative to WE 
men.  Similarly, we recently showed that reactive hyperaemia and vasodilator responses to 
mental stress were blunted in forearm of young normotensive SA men, relative to WE men 
[36].  Moreover, FMD and the tonic dilator influence of NO on forearm were also blunted in 
young normotensive SA, relative to WE men [37]. Indeed, it seems endothelium-dependent 
dilatation is impaired even in young SA men with no overt CVD. 
Nevertheless, a key finding of the present study is that in both young WE and SA men, COX 
inhibition attenuated reactive hyperaemia and ACh-evoked dilatation in cutaneous circulation 
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of ON, just as in the full group of mixed ethnicity.  Given the heritable proportion of ABP is 
40-60% in WEs and SAs [1,4], it may be the future risk of hypertension is lower in the 
minority of individual OH in whom COX inhibition attenuates cutaneous dilator responses, 
but higher in those in whom responses are augmented.  Factors such as central obesity, 
physical inactivity, high life stress and hyper-responsiveness to stressors determine whether 
individual OH, or ON develop hypertension [1-4,38] and the prevalence of central obesity and 
diabetes is higher among SAs [35].  Thus, it would not be surprising if the proportion of OH 
men who actually develop hypertensive and CVD were greater amongst SAs than WEs.   
Study Limitations  
Like most studies on ON/OH [see 6-8], we did not verify whether the parents of ON had 
hypertension.  Thus, some may have been undiagnosed, or develop hypertension in the future.  
However, young OH men whose parents have hypertension in early middle-age are at higher 
risk of hypertension than those whose parents develop hypertension in late middle-age [39].  
It is therefore reasonable to assume the OH men were the higher risk group.  It is a limitation 
that we assessed BMI but not body fat distribution. However, in a recent study, BMI, waist: 
hip ratio and fasting glucose levels were similar in young SA and WE men, but fasting insulin 
was at the high end of the normal range in SAs, consistent with their depressed endothelium-
dependent dilatation [37].  Thus, we have missed early signs of diabetes in some SA men.  
Importantly, our proposals should be tested in a larger population of young men and women.  
 
Considering our experimental stimuli, release of sensory nerve peptides has been implicated 
in reactive hyperaemia and vasodilatation evoked by iontophoresis of ACh [26,33].
 
 We used 
a shorter period of arterial occlusion (3 vs 5min) and delivered ACh with a lower current than 
those studies.
  
Moreover, we showed that iontophoresis of vehicle with the same protocol as 
we used for ACh had minimal effects on cutaneous perfusion, while COX inhibition had no 
effect on responses evoked by iontophoresis of the endothelium-independent dilator sodium-
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nitroprusside [17,18].  Thus, whilst we cannot exclude involvement of neuropeptides released 
directly by ischaemia or current, or by their ability to stimulate synthesis of mediators, such as 
PGs [26,33], it seems reasonable to assume the responses we report mainly reflect direct 
effects of ischemia and ACh on endothelium-dependent dilatation.  
Conclusions 
The present study on normotensive men in the 19-24 y age range, indicates that OH men of 
WE and SA ethnicity show blunted reactive hyperaemia and ACh-evoked vasodilatation in 
cutaneous circulation relative to ON men, attributable to a depressed contribution of 
vasodilator PGs.  These early signs of endothelial dysfunction precede development of frank 
hypertension, but may contribute causally to its pathogenesis [40]. 
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ON  OH  P value 
Number of subjects 12 12  
Age (years) 21.1±0.3 20.7±0.4 NS 
BMI (Kg/m
2
) 24.4±0.9  22.9±0.3  NS 
Systolic BP (mmHg)  121.1±3.3 122.3±1.7 NS 
Diastolic BP (mmHg) 74.9±2.8  76.8±1.6  NS 
MABP (mmHg) 90.3±2.8 91.9±1.4 NS 
Alcohol units/wk  2.1±0.7 3.2±1.2 NS 
Caffeine beverages/day  0.4±0.2 0.4±0.3 NS 
Vit C-containing portions/day  2.8±0.3 3.1±0.4 NS 
Oily Fish portions/wk  1.9±0.3 1.2±0.3 NS 
Physical activity/wk  3.1±0.2 2.9±0.2 NS 
 
Table 1. Characteristics of ON and OH subjects. Vit C-containing portions; high Vitamin C-
containing fruit and vegetable portions. Physical activity rated as sedentary (minimal), elective 
exercise: low (30min<3 times/week), medium (30min≤3 times/week), high intensity (30min>3 
times/week) scored as 0-4 respectively. NS, P>0.05; ON vs OH. 
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WE  SA  P value 
Number of subjects 12 12  
Age (years) 20.3±0.3 21.6±0.4 NS 
BMI (Kg/m
2
) 23.2±0.6  24.3±0.5  NS 
Systolic BP (mmHg)  119±2.9 124.4±1.9 NS 
Diastolic BP (mmHg) 72.9±2.1 78.75±2.0
#
 <0.05 
MABP (mmHg) 88.3±2.2 93.9±1.9
#
 <0.05 
Alcohol units/wk  3.2±0.5 2.3±1.4 NS 
Caffeine beverages/day  0.4±0.3 0.4±0.2 NS 
Vit-C containing portions/day  2.9±0.3 3.0±0.4 NS 
Oily Fish portions/wk  1.7±0.3 1.2±0.3 NS 
Physical activity/wk  2.9±0.2 3.2±0.2 NS 
Table 2.  Characteristics of WE and SA subjects.  Abbreviations as in Table 1. NS, 
#
: 
P>0.05, P<0.05 respectively; SA vs WE.  
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Figure 1. Reactive hyperemia in OH and ON men before and after aspirin.  A, B: control 
responses in ON and OH respectively, before and after aspirin. C, D peak reactive hyperaemia 
(RH) in individual ON and OH respectively, before and after aspirin; individual data 
connected by fine line.  Cross-hatched squares indicate mean peak responses ±SEM; before 
and after aspirin connected by thick line.  **, *: p<0.001, P<0.05 respectively within group 
before vs after aspirin. 
#, §
: p<0.05 between ON and OH groups before and after aspirin 
respectively. 
Figure 2. Vascular responses evoked by ACh in OH and ON men before and after 
aspirin. A, B: control responses in ON and OH respectively, before and after aspirin.  C, D: 
mean dilator response to ACh in individual OH and ON respectively, before and after aspirin; 
individual data connected by fine line. Cross-hatched squares indicate mean ACh responses 
±SEM; before and after aspirin connected by thick line.  **, *: P<0.001, P<0.05 respectively 
before vs after aspirin for mean response to ACh.  
# § 
: p<0.05 between ON and OH groups 
before and after aspirin respectively.  
Figure 3. Reactive Hyperaemia in WE and SA men before and after aspirin.  A: control 
responses in WEs and SAs; B: responses in WEs and SAs after aspirin; C,D: responses in ON 
WEs and SAs before and after aspirin.  E, F: responses in OH WEs and SAs before and after 
aspirin. *: P<0.05 within WE, or SA, before vs after aspirin. 
Figure 4. Vascular responses evoked by ACh in WE and SA men before and after 
aspirin.  A: control responses in WEs and SAs; B: responses in WEs and SAs after aspirin; C, 
D: responses in ON WEs and SAs before and after aspirin; E, F: responses in OH WEs and 
SAs before and after aspirin;.  
#
: P<0.05 between WE and SA groups. *: P<0.05 within WE, 
or SA, before vs after aspirin. 
